Delivery Order SPE2DB24D1201-SPE2DB25FJAKV
Award Date
11/12/24
Potential Completion Date
12/4/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the provision of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The $1,288.86 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and was awarded on January 28, 2025. No set-aside designation was used for this award. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,718.48, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $4,845.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Envarsus XR 4 mg tablets, with a completion date of November 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,216.11 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 4, 2024, with a completion date of September 25, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets to the U.S. government. The $1,553.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a completion date of July 21, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,677.52 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 27, 2024. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.95, is for the delivery of Envarsus XR 4 mg tablets. The contract is a firm fixed-price delivery order with a completion date of May 7, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The $6,461.32 firm-fixed price contract was awarded on April 24, 2024 to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, with a period of performance through May 15, 2024. The contract is not designated as a set-aside and was awarded under a larger Indefinite Delivery...
This federal contract award is for the delivery of Envarsus XR 0.75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024, with a ceiling value of $1,216.48 and a completion date of August 14, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen has been awarded numerous federal contracts by various agencies, including a...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $9,391.86, with a firm fixed price. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...